FOLH1 and prostate cancer: Zhang et al. also reported very high sensitivity and specificity (all values > 93%) for both [68Ga]Ga-PSMA-11 PET-CT and mpMRI for the primary detection of LNI in patients with intermediate-to-high-risk prostate cancer, which was partly due to the use of a 3T scanner, and a high proportion (>80%) of enlarged (>10 mm) metastatic nodes [41].